Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIV | ITCI | RGEN | ||
| Company | Roivant Sciences Ltd | Intra-Cellular Ther | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.65 | 85.51 | 139.61 | ||
| High | 11.97 | 86.05 | 142.11 | ||
| Low | 11.62 | 84.38 | 136.54 | ||
| Last | 11.82 | 85.45 | 141.76 | ||
| Change | +0.33 | -0.19 | +2.86 | ||
| % Change | +2.87% | -0.22% | +2.06% | ||
| Volume | 7,197,500 | 390,100 | 660,000 | ||
| 20-Day Average Volume | 4,562,355 | 770,540 | 706,255 | ||
| Previous Close | 11.49 | 85.64 | 138.90 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.65 | 85.45 | 138.55 | ||
| 20-Day Raw Stochastic | 72.09% | 56.04% | 61.41% | ||
| 20-Day Relative Strength | 52.84% | 57.15% | 51.22% | ||
| Weighted Alpha | +24.95 | +43.55 | -15.14 | ||
| Today's Opinion | 72% Buy | 96% Buy | 72% Sell | ||
| Previous Opinion | 40% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 64% Buy | 88% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.55% since 11/14/24 | -2.49% since 11/14/24 | -0.47% since 11/14/24 | ||
| Low | 11.05 on 11/18/24 | 81.83 on 11/18/24 | 121.52 on 11/15/24 | ||
| High | 11.97 on 11/21/24 | 87.12 on 11/15/24 | 142.11 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +1.72% since 10/21/24 | +11.10% since 10/21/24 | -4.99% since 10/21/24 | ||
| Low | 11.05 on 11/18/24 | 74.76 on 10/23/24 | 121.52 on 11/15/24 | ||
| High | 12.12 on 11/11/24 | 93.45 on 11/11/24 | 154.48 on 11/12/24 | ||
| 3-Month | |||||
| %Chg | +0.25% since 08/21/24 | +12.89% since 08/21/24 | -7.32% since 08/21/24 | ||
| Low | 11.05 on 11/18/24 | 70.90 on 10/07/24 | 121.52 on 11/15/24 | ||
| High | 13.06 on 09/09/24 | 93.45 on 11/11/24 | 154.48 on 11/12/24 | ||
| 6-Month | |||||
| %Chg | +5.25% since 05/21/24 | +27.54% since 05/21/24 | -15.06% since 05/21/24 | ||
| Low | 10.00 on 08/05/24 | 64.72 on 05/29/24 | 113.50 on 06/20/24 | ||
| High | 13.06 on 09/09/24 | 93.45 on 11/11/24 | 172.65 on 08/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,741,149 | 9,059,151 | 7,942,388 | ||
| Shares Outstanding, K | 739,522 | 106,017 | 56,027 | ||
| Annual Sales | 124,800,000 | 464,370,000 | 638,760,000 | ||
| Annual Net Income | 4,348,930,000 | -139,670,000 | 41,580,000 | ||
| Last Quarter Sales | 4,480,000 | 175,380,000 | 154,870,000 | ||
| Last Quarter Net Income | -230,180,000 | -26,320,000 | -650,000 | ||
| 60-Month Beta | 1.24 | 0.97 | 0.96 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 11/12/24 | -0.25 on 10/30/24 | 0.43 on 11/12/24 | ||
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 101.39 | ||